5265 articles
David Spetzler, President and Chief Scientific Officer at Caris® Life Sciences discusses partnering with Merus, a clinical-stage oncology company, to d...
Avi Fischer, M.D., Divisional Vice President, MedicalAffairs, and Chief Medical Officer for Cardiac RhythmManagement (CRM) at Abbott discusses the recen...
Ruby Gadelrab, CEO and Co-founder of MDisrupt, the first-of-its-kind medical diligence company, discusses how they are helping health-tech startups demo...
Wesley Gilson, Ph.D., Artificial Intelligence Lead for Siemens Healthineers North America discusses the idea that an AI revolution in healthcare is not ...
Kathryn Lang, vice president of Health Outcomes and Evidence at Guardant Health discusses research highlighting the significance of its LUNAR-2 liquid b...
Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, the first company to gain FDA approval of a peanut allergy treatment, PALFORZI...
Susan Mitmesser, VP of Science and Technology at Pharmavite, makers of Nature Made vitamins and supplements, discusses a review paper by Pharmavite that...
Daniel Simon discusses the GuardantINFORM™ platform featuring an extensive clinical-genomic liquid biopsy dataset of advanced cancer patients.
Galderma's "Beyond the visible: rosacea and psoriasis of the face" is a global survey involving over 600 patients with facial skin disease (rosacea or p...
Carlos Doti discusses the results from two trials - Ph.2 ACE-CL-001 and Ph.3 ASCEND, that was presented at the virtual edition of the European Hematolog...